AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23886411 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed whey (hWHEY) protein meal
Number of subjects: 12
Study 23886411 — intervention group
Group type: COMPARATOR
Intervention: Hydrolyzed casein (hCAS) and hydrolyzed whey (hWHEY) protein meals
Number of subjects: 12
Study 23886411 — intervention group
Group type: COMPARATOR
Intervention: Leucine co-ingestion
Number of subjects: 12
Study 22575166 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU-v low dose (250 μg) adjuvanted
Number of subjects: 48
Study 22575166 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU-v high dose (500 μg) adjuvanted
Number of subjects: 48
Study 22575166 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU-v (both doses)
Number of subjects: 48
Study 22575166 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU-v (all formulations)
Number of subjects: 48
Study 20307800 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxification program characteristics (accreditation, fewer beds, longer stays, shorter distance between detoxification and outpatient unit, larger city population)
Number of subjects: 632
Study 18852411 — intervention group
Group type: EXPERIMENTAL
Intervention: Office-based vergence/accommodative therapy with home reinforcement (OBVAT)
Number of subjects: 221
Study 18852411 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based computer vergence/accommodative therapy and pencil push-ups (HBCVAT+)
Number of subjects: 221
Study 18852411 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pencil push-ups (HBPP)
Number of subjects: 221
Study 18852411 — intervention group
Group type: COMPARATOR
Intervention: Office-based placebo therapy with home reinforcement (OBPT)
Number of subjects: 221
Study 15909196 — intervention group
Group type: EXPERIMENTAL
Intervention: CT with IV contrast agent
Number of subjects: 19
Study 15909196 — intervention group
Group type: COMPARATOR
Intervention: CT without IV contrast agent
Number of subjects: 19
Study 15909196 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical evaluation by two specialists
Number of subjects: 19
Study 12206610 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrin sealant (FS)
Number of subjects: 28
Study 12206610 — intervention group
Group type: COMPARATOR
Intervention: Bovine thrombin (T)
Number of subjects: 28
Study 12206610 — intervention group
Group type: COMPARATOR
Intervention: Pressure (P)
Number of subjects: 28
Study 12206610 — intervention group
Group type: COMPARATOR
Intervention: Bovine thrombin-soaked cellulose sponges (TG)
Number of subjects: 28
Study 12206610 — intervention group
Group type: COMPARATOR
Intervention: Oxidized regenerated cellulose (S)
Number of subjects: 28
Study 10612136 — intervention group
Group type: EXPERIMENTAL
Intervention: Ho-Yag laser
Number of subjects: 76
Study 10612136 — intervention group
Group type: COMPARATOR
Intervention: Mechanical meniscectomy
Number of subjects: 76
Study 7717281 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan potassium
Number of subjects: 2900
Study 7717281 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2900
Study 7717281 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin-converting enzyme inhibitors
Number of subjects: 2900
Study 7717281 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 2900
Study 7717281 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan monotherapy
Number of subjects: 2900
Study 7717281 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan + Hydrochlorothiazide
Number of subjects: 2900
Study 2045618 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated referral to an asthma specialist
Number of subjects: 309
Study 2045618 — intervention group
Group type: COMPARATOR
Intervention: Continued outpatient management from generalist physicians
Number of subjects: 309
Study 6516811 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (100 micrograms)
Number of subjects: 27
Study 6516811 — intervention group
Group type: COMPARATOR
Intervention: Control (0.25 ml 0.9% NaCl)
Number of subjects: 27
Study 29410014 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of baricitinib
Number of subjects: 124
Study 29410014 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of baricitinib
Number of subjects: 124
Study 29410014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 28478725 — intervention group
Group type: EXPERIMENTAL
Intervention: Head CT examination
Number of subjects: 147
Study 28478725 — intervention group
Group type: COMPARATOR
Intervention: In-hospital observation
Number of subjects: 147
Study 26207537 — intervention group
Group type: EXPERIMENTAL
Intervention: DIEP group (classical DIEP flap using 1 venous anastomosis)
Number of subjects: 52
Study 26207537 — intervention group
Group type: COMPARATOR
Intervention: DIEP-TAsc group (thoracoacromial venous supercharged DIEP flap using the ipsilateral superficial epigastric vein)
Number of subjects: 52
Study 24892803 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite Variability Index (CVI)
Number of subjects: 120
Study 24892803 — intervention group
Group type: EXPERIMENTAL
Intervention: Bispectral Index (BIS)
Number of subjects: 120
Study 24892803 — intervention group
Group type: COMPARATOR
Intervention: Heart Rate (HR)
Number of subjects: 120
Study 24892803 — intervention group
Group type: COMPARATOR
Intervention: Mean Arterial Blood Pressure (MAP)
Number of subjects: 120
Study 24892803 — intervention group
Group type: COMPARATOR
Intervention: Predicted remifentanil effect‐site concentrations (CeREMI)
Number of subjects: 120
Study 24892803 — intervention group
Group type: COMPARATOR
Intervention: Propofol effect‐site concentration
Number of subjects: 120
Study 22696825 — intervention group
Group type: EXPERIMENTAL
Intervention: Rest in the left lateral position (n = 77)
Number of subjects: 152
Study 22696825 — intervention group
Group type: COMPARATOR
Intervention: Mild activity (sitting and walking) (n = 75)
Number of subjects: 152
Study 20167175 — intervention group
Group type: EXPERIMENTAL
Intervention: Veo calibration algorithm
Number of subjects: 0
Study 20167175 — intervention group
Group type: COMPARATOR
Intervention: Standard calibration
Number of subjects: 0
Study 18690839 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective statin use
Number of subjects: 0
Study 18690839 — intervention group
Group type: EXPERIMENTAL
Intervention: All lipid-lowering agents (LLA) use (statin and non-statin LLA)
Number of subjects: 0
Study 18690839 — intervention group
Group type: COMPARATOR
Intervention: Statin users
Number of subjects: 0
Study 15867780 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine Carpentier‐Edwards Perimount bioprosthesis
Number of subjects: 136
Study 15867780 — intervention group
Group type: COMPARATOR
Intervention: Porcine Medtronic Mosaic bioprosthesis
Number of subjects: 136
Study 15867780 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine Carpentier‐Edwards Perimount bioprosthesis size 23
Number of subjects: 136
Study 15867780 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine Medtronic Mosaic bioprosthesis size 25
Number of subjects: 136
Study 15867780 — intervention group
Group type: EXPERIMENTAL
Intervention: Both bioprostheses
Number of subjects: 136
Study 12706228 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow repetitive transcranial magnetic stimulation (rTMS) over the striate cortex
Number of subjects: 0
Study 12706228 — intervention group
Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 0
Study 10574477 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone, oral glutamine, and high-carbohydrate-low-fat (HCLF) diet
Number of subjects: 8
Study 10574477 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 8
Study 8966026 — intervention group
Group type: EXPERIMENTAL
Intervention: LCP-F (formula supplemented with long-chain polyunsaturates)
Number of subjects: 22
Study 8966026 — intervention group
Group type: COMPARATOR
Intervention: Conventional infant formula (without long-chain polyunsaturates)
Number of subjects: 22
Study 1830450 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone 100 mg
Number of subjects: 28
Study 1830450 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoximone 25 mg
Number of subjects: 28
Study 1830450 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 6357203 — intervention group
Group type: EXPERIMENTAL
Intervention: cetraxate
Number of subjects: 0
Study 6357203 — intervention group
Group type: COMPARATOR
Intervention: aldioxa
Number of subjects: 0
Study 31483750 — intervention group
Group type: EXPERIMENTAL
Intervention: HPLC-MRM-IDA-EPI analytical method for detecting chemotherapy drugs
Number of subjects: 743
Study 31483750 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary tandem mass spectrometry approach
Number of subjects: 743
Study 30325565 — intervention group
Group type: EXPERIMENTAL
Intervention: vNOTES
Number of subjects: 70
Study 30325565 — intervention group
Group type: COMPARATOR
Intervention: TLH
Number of subjects: 70
Study 28234265 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic Walking training (12 weeks, 3 times a week, 1 hour)
Number of subjects: 39
Study 28234265 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study 25568411 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of subchondral bone plate (SCBP)
Number of subjects: 50
Study 25568411 — intervention group
Group type: COMPARATOR
Intervention: Retention of subchondral bone plate (SCBP)
Number of subjects: 50
Study 23292545 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CM)
Number of subjects: 208
Study 23292545 — intervention group
Group type: COMPARATOR
Intervention: Western medicine (WM)
Number of subjects: 208
Study 22462692 — intervention group
Group type: EXPERIMENTAL
Intervention: TheraTogs (a corset with elasticated strapping) applied to support hip extensor and abductor musculature for 5 weeks or until patients reach Functional Ambulation category 5.
Number of subjects: 120
Study 22462692 — intervention group
Group type: COMPARATOR
Intervention: Cane walking held at the level of the radial styloid of the sound wrist for 5 weeks or until patients reach Functional Ambulation category 5.
Number of subjects: 120
Study 19019053 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound perfusion with 8 mL of 0.25% bupivacaine every 5 hours
Number of subjects: 50
Study 19019053 — intervention group
Group type: COMPARATOR
Intervention: Intravenous pethidine 0.2 mg/kg on demand
Number of subjects: 50
Study 17320546 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic colorectal resections (LCRs)
Number of subjects: 40
Study 17320546 — intervention group
Group type: COMPARATOR
Intervention: Open colorectal resections (OCRs)
Number of subjects: 40
Study 15117890 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist plus raloxifene (leuprolide acetate depot at 3.75 mg/28 days and raloxifene hydrochloride at 60 mg/day for 18 cycles)
Number of subjects: 50
Study 12200524 — intervention group
Group type: EXPERIMENTAL
Intervention: eformoterol Turbohaler 9 microg (delivered dose)
Number of subjects: 663
Study 12200524 — intervention group
Group type: COMPARATOR
Intervention: budesonide Turbohaler 400 microg twice daily
Number of subjects: 663
Study 9618752 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) up to 0.25 U/kg per week in daily doses
Number of subjects: 20
Study 9618752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9618752 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (GH)
Number of subjects: 20
Study 7659635 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive computer program
Number of subjects: 100
Study 7659635 — intervention group
Group type: COMPARATOR
Intervention: Audio tape
Number of subjects: 100
Study 1837965 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.150 mg Desogestrel and 0.030 mg Ethinylestradiol
Number of subjects: 308
Study 1837965 — intervention group
Group type: COMPARATOR
Intervention: 0.075 mg Gestoden and 0.030 mg Ethinylestradiol
Number of subjects: 308
Study 1837965 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.250 mg Norgestimat and 0.035 mg Ethinylestradiol
Number of subjects: 308
Study 6792566 — intervention group
Group type: EXPERIMENTAL
Intervention: Vulnerable-Experimental group (119 trainees) required to report to the CMHA Early Intervention Program
Number of subjects: 269
Study 6792566 — intervention group
Group type: COMPARATOR
Intervention: Vulnerable-Control group (150 trainees) not required to report to the CMHA Early Intervention Program
Number of subjects: 269
Study 30548252 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC)
Number of subjects: 58
Study 30548252 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 58
Study 29102044 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nail
Number of subjects: 1000
Study 29102044 — intervention group
Group type: COMPARATOR
Intervention: Sliding Hip Screw
Number of subjects: 1000
Study 25211767 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination hearing aid with noise feature activated (experimental group, n=15)
Number of subjects: 30
Study 25211767 — intervention group
Group type: COMPARATOR
Intervention: Hearing aids alone (control group, n=15)
Number of subjects: 30
Study 24849708 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 150 mg (arm A)
Number of subjects: 81
Study 24849708 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintedanib 250 mg (arm B)
Number of subjects: 81
Study 24849708 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 81
Study 23151699 — intervention group
Group type: EXPERIMENTAL
Intervention: Opal self-ligating brackets (SLBs)
Number of subjects: 14
Study 23151699 — intervention group
Group type: COMPARATOR
Intervention: Conventional standard metal manually ligating brackets (MLBs)
Number of subjects: 14
Study 19687168 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery and rhTSH stimulation
Number of subjects: 25
Study 19687168 — intervention group
Group type: COMPARATOR
Intervention: Surgery and l-T(4) abstinence
Number of subjects: 25
Study 17312403 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal (IN) measles vaccine
Number of subjects: 0
Study 17312403 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous (SQ) measles vaccine
Number of subjects: 0
Study 17312403 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IN and SQ vaccines
Number of subjects: 0
Study 15498746 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing intervention (writing about an emotional topic)
Number of subjects: 106
Study 15498746 — intervention group
Group type: COMPARATOR
Intervention: Neutral writing topic (control)
Number of subjects: 106
Study 11588753 — intervention group
Group type: EXPERIMENTAL
Intervention: MagnaBloc (n = 38)
Number of subjects: 64
Study 11588753 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 26)
Number of subjects: 64
Study 9530462 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 8082354 — intervention group
Group type: EXPERIMENTAL
Intervention: Spacer device with inhaled beta-agonist at discharge
Number of subjects: 84
Study 8082354 — intervention group
Group type: COMPARATOR
Intervention: Inhaled or oral beta-agonists without a spacer device
Number of subjects: 84
Study 2683547 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg
Number of subjects: 17
Study 2683547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 150 mg
Number of subjects: 17
Study 2683547 — intervention group
Group type: COMPARATOR
Intervention: No H2 receptor antagonist (Control)
Number of subjects: 17
Study 747177 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 25 mg first-day dose
Number of subjects: 42
Study 747177 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg first-day dose
Number of subjects: 42
Study 747177 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone 150 mg first-day dose
Number of subjects: 42
Study 747177 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone maintenance regimen in Group A (5 times weekly)
Number of subjects: 42
Study 747177 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone maintenance regimen in Group B (3 times weekly)
Number of subjects: 42
Study 747177 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone maintenance regimen in Group C (2 times weekly)
Number of subjects: 42
Study 31987769 — intervention group
Group type: COMPARATOR
Intervention: High dose (HD) group received 4 mg of folic acid daily from the first 3 months of pregnancy until the entire pregnancy.
Number of subjects: 1576
Study 31987769 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose (LD) group received 0.4 mg of folic acid daily from the first 3 months of pregnancy until the entire pregnancy.
Number of subjects: 1576
Study 31987769 — intervention group
Group type: COMPARATOR
Intervention: High dose (HD) group with compliance >50%.
Number of subjects: 1576
Study 30407046 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led Seeking Safety (PL-SS)
Number of subjects: 278
Study 30407046 — intervention group
Group type: COMPARATOR
Intervention: Clinician-led Seeking Safety (CL-SS)
Number of subjects: 278
Study 28237842 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (mobile application)
Number of subjects: 84
Study 28237842 — intervention group
Group type: COMPARATOR
Intervention: Control (standard risk counseling)
Number of subjects: 84
Study 26173038 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated SMS program supplementing a 25-session youth development program
Number of subjects: 221
Study 23990989 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief outreach academic detailing intervention
Number of subjects: 46
Study 23990989 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention beyond receiving guidelines)
Number of subjects: 46
Study 21248209 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based telerehabilitation program
Number of subjects: 65
Study 21248209 — intervention group
Group type: COMPARATOR
Intervention: Conventional outpatient physical therapy
Number of subjects: 65
Study 19793643 — intervention group
Group type: EXPERIMENTAL
Intervention: Pegylated interferon‐alpha‐2b
Number of subjects: 299
Study 19793643 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 299
Study 19793643 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive RT‐PCR sample
Number of subjects: 299
Study 19793643 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative RT‐PCR sample
Number of subjects: 299
Study 17476525 — intervention group
Group type: EXPERIMENTAL
Intervention: Active muscle stretch (15, 25, and 35 degrees at a velocity of 60 degrees s(‐1))
Number of subjects: 15
Study 17476525 — intervention group
Group type: EXPERIMENTAL
Intervention: Active muscle stretch
Number of subjects: 15
Study 15100594 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 45
Study 15100594 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrotherapy
Number of subjects: 45
Study 15100594 — intervention group
Group type: COMPARATOR
Intervention: Patient education alone
Number of subjects: 45
Study 11706977 — intervention group
Group type: EXPERIMENTAL
Intervention: Convergence retraction nystagmus (CRN)
Number of subjects: 1
Study 11706977 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 1
Study 9340922 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraphysiologic magnesium administration
Number of subjects: 0
Study 9340922 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 8432466 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (200 mg)
Number of subjects: 10
Study 8432466 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3319722 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxiconazole cream, applied once daily
Number of subjects: 0
Study 30384034 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco control advocacy capacity-building programme
Number of subjects: 1245
Study 30384034 — intervention group
Group type: COMPARATOR
Intervention: Control group (public health undergraduate students from 11 universities)
Number of subjects: 1245
Study 27575834 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with 50 J dose
Number of subjects: 28
Study 27575834 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with 10 J dose
Number of subjects: 28
Study 27575834 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with 10 J and 50 J doses
Number of subjects: 28
Study 27575834 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with 30 J dose
Number of subjects: 28
Study 24689258 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive load (high load conditions with a concurrent working memory task using auditory stimuli)
Number of subjects: 0
Study 24689258 — intervention group
Group type: COMPARATOR
Intervention: Control (steady lane position without cognitive load)
Number of subjects: 0
Study 22278428 — intervention group
Group type: EXPERIMENTAL
Intervention: HyEx60 (60 min of continuous exercise at 90% lactate threshold in hypoxia)
Number of subjects: 8
Study 22278428 — intervention group
Group type: EXPERIMENTAL
Intervention: Hy5:5 (intermittent exercise at 120% lactate threshold in hypoxia)
Number of subjects: 8
Study 22278428 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxia (intermittent exercise at 120% lactate threshold in normoxia)
Number of subjects: 8
Study 20227726 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐year recreational physical activity program (3 90‐minute sessions per week for 28 weeks each year)
Number of subjects: 1044
Study 20227726 — intervention group
Group type: EXPERIMENTAL
Intervention: 2‐year recreational physical activity program
Number of subjects: 1044
Study 18381502 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider- and peer-delivered intervention (based on the 5A model) consisting of brief counseling and follow-up visits/calls.
Number of subjects: 2711
Study 18381502 — intervention group
Group type: COMPARATOR
Intervention: Usual care control condition.
Number of subjects: 2711
Study 16630310 — intervention group
Group type: EXPERIMENTAL
Intervention: Active occlusal interference
Number of subjects: 11
Study 16630310 — intervention group
Group type: COMPARATOR
Intervention: Dummy interference
Number of subjects: 11
Study 16630310 — intervention group
Group type: COMPARATOR
Intervention: Interference-free condition
Number of subjects: 11